SR
Subba Rao Parupalli
About Subba Rao Parupalli
Data last updated:
Subba Rao Parupalli was a Cfo at Cohance Lifesciences Limited (2018–2024), Cfo(Kmp) at Suven Life Sciences Limited (2015–2020) and Director at Suraj Drugs Private Limited (from 2001), and held 1 more directorship. The companies operate in Pharma.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Cohance Lifesciences Limited L24299MH2018PLC422236 | Cfo | 06 Nov 2018 | |||
 Suven Life Sciences Limited L24110TG1989PLC009713 | Cfo(Kmp) | 10 Feb 2015 | 1989 | ₹17.55 Cr (FY 2025) | Active |
| Suraj Drugs Private Limited U24239TG1994PTC018757 | Director | 14 Feb 2001 | 1994 | Strike Off | |
| Suven Nishtaa Pharma Private Limited U24232TG2007PTC052851 | Director | 16 Mar 2009 | 2007 | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Subba Rao Parupalli
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Subba Rao Parupalli
Subba Rao Parupalli was first appointed on 14 Feb 2001 as Director at Suraj Drugs Private Limited. The most recent appointment on record is 06 Nov 2018 at Cohance Lifesciences Limited.
Subba Rao Parupalli held 4 earlier board appointments: Cohance Lifesciences Limited (Cfo, 06 Nov 2018 to 02 Jan 2024); Suven Life Sciences Limited (Cfo(Kmp), 10 Feb 2015 to 10 Jan 2020); Suraj Drugs Private Limited (Director, from 14 Feb 2001); Suven Nishtaa Pharma Private Limited (Director, from 16 Mar 2009).